Try our Advanced Search for more refined results
- September 23, 2022 Bristol-Myers Must Face Celgene Deal Suit In NJ State Court
- July 11, 2022 Venue Issues Drug Cos. Should Watch In Hatch-Waxman Suits
- June 24, 2022 Bristol-Myers Can't Dodge Celgene Investors' Drug Delay Suit
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS